Both in Pharmaceuticals
Oncolytics Biotech vs Citius Oncology
Over the past year ONCY returned −63.4% and CTOR returned −69.7%; their daily moves had a correlation of 0.18.
ONCY −63.4% CTOR −69.7%Growth of $1, one year, split-adjusted
| Metric | ONCY | CTOR |
|---|---|---|
| Price | $0.4277 | $0.5295 |
| Market cap | $56.1M | $56.0M |
| Today | −3.15% | −8.20% |
| 1 month | −36.0% | −47.6% |
| 6 months | −51.4% | −39.8% |
| Year to date | −51.1% | −47.0% |
| 1 year | −64.9% | −69.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 67.1% |
| Net margin | — | −597.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 7.9× |
| Net cash | $4.1M | $10.2M |
| Dividend yield | — | — |
| Volatility (60d) | 63.7% | 96.2% |
| Short % of float | 7.4% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).